Institutional Subscriptions   Individual Subscriptions 
Editors/Authors   Librarians   Newsletter   Site Tour   A-Z Index   About   Contact Us   Help 
Log In | Log In via Athens
Disable Autosuggest
Users' Guides to the Medical Literature
Guyatt G, Rennie D, Meade MO, Cook DJ
Part B Therapy
Chapter 10.4. Composite Endpoints
Gordon Guyatt, Victor Montori, Ignacio Ferreira-González, Jason W. Busse, Holger Schünemann, Roman Jaeschke, Gaietà Permanyer-Miralda
The LIFE trial9 investigators randomized 9193 patients older than 55 years, with...

Topics Discussed: aspirin, atherosclerosis, clopidogrel, composite endpoints, confidence interval, diabetic nephropathy, health outcomes, hypertension, relative risk reduction

Excerpt: "Comfort with using a CEP as the basis of clinical decision making rests in part on confidence that similar RRRs apply to the more and the less important components. Investigators should therefore construct CEPs in which the biology would lead us to expect similar effects across components...."
Log in to read the full chapter:
Subscriber Log In
Forgot your username/password?
Get full access to JAMAevidence two ways:
Subscribe to JAMAevidence
JAMAevidence is a subscription-
based website dedicated to the learning, teaching, and practicing of evidence-based medicine.
Pay Per View
Timed access to all of JAMAevidence
24 hours for $34.95
48 hours for $54.95
Copyright © American Medical Association. All rights reserved.  |  JAMA  |  McGraw-Hill Global Education Holdings, LLC.
Privacy Notice. Any use is subject to the Terms of Use and Notice. Additional Credits and Copyright Information.
Your IP address is